Skip to content
  • Friday, June 6, 2025

New Economy World

The world economy is the economy of all humans in the world

Banner Add
  • Home
  • Blog
  • Finance News
  • Insurance
  • Investing
  • Construction
  • Property
  • Stock
  • Tech
  • Venture Capital
  • Home
  • Stock
  • Analysis-Unilever faces battle to reduce plant-based meat exposure
Stock

Analysis-Unilever faces battle to reduce plant-based meat exposure

25/02/2025
admin


Analysis-Unilever faces battle to reduce plant-based meat exposure#AnalysisUnilever #faces #battle #reduce #plantbased #meat #exposure

Tags: AnalysisUnilever, battle, Exposure, Faces, Meat, plantbased, reduce

Post navigation

Rethinking the route to net zero
Fairlight Alpha Fund Q4 2024 Letter

Finance and Economics

Recent Posts

Finance News

DocuSign, Inc. (DOCU) Q1 2026 Earnings Call Transcript

06/06/2025
admin
Stock

RAD 2025: Long-Term Data on Nemluvio ® (nemolizumab) Demonstrate its Favorable Safety Profile and Sustained and Increased Improvements in Itch and Skin Lesions in Patients With Atopic Dermatitis up to

06/06/2025
admin
Finance News

Rubrik, Inc. (RBRK) Q1 2026 Earnings Call Transcript

06/06/2025
admin
Stock

bernstein socgen group cuts crowdstrike stock rating to market perform

06/06/2025
admin
Finance News

Whitehaven Coal: Caught In The Political Crossfire

06/06/2025
admin
Stock

India cenbank delivers larger-than-expected 50 bps cut in key rate

06/06/2025
admin
Finance News

ChargePoint: Weak Quarter And Disappointing Outlook – Sell (Rating Downgrade)

06/06/2025
admin

Recent Posts

Finance News

DocuSign, Inc. (DOCU) Q1 2026 Earnings Call Transcript

06/06/2025
admin
Stock

RAD 2025: Long-Term Data on Nemluvio ® (nemolizumab) Demonstrate its Favorable Safety Profile and Sustained and Increased Improvements in Itch and Skin Lesions in Patients With Atopic Dermatitis up to

06/06/2025
admin

Recent Posts

Finance News

DocuSign, Inc. (DOCU) Q1 2026 Earnings Call Transcript

06/06/2025
admin
Stock

RAD 2025: Long-Term Data on Nemluvio ® (nemolizumab) Demonstrate its Favorable Safety Profile and Sustained and Increased Improvements in Itch and Skin Lesions in Patients With Atopic Dermatitis up to

06/06/2025
admin

Recent Posts

Finance News

DocuSign, Inc. (DOCU) Q1 2026 Earnings Call Transcript

06/06/2025
admin
Stock

RAD 2025: Long-Term Data on Nemluvio ® (nemolizumab) Demonstrate its Favorable Safety Profile and Sustained and Increased Improvements in Itch and Skin Lesions in Patients With Atopic Dermatitis up to

06/06/2025
admin
New Economy World News